vTv Therapeutics Inc. (VTVT) insider have most recently took part in a trading activity. On Dec 7, 2017 Savas Paul G, Director bought 15,000 shares having total worth of $68,400 at the price of $4.56 per share, following the transaction a total of 86,781 shares owned by Savas Paul G. Before this latest buy, Savas Paul G purchased VTVT at 2 other times during the past twelve months, for a total investment of $80,540 at an average of $5.84 per share.
Furthermore, over the past 12 months , the stock was traded 6 times by insiders. an employee of the company was the buyer in 6 instances.
Shares of vTv Therapeutics Inc. (VTVT) traded up 22.56% on Dec 6, 2017, hitting $4.78. 113,207 shares of the company’s stock traded hands. vTv Therapeutics Inc. has a 52 week low of $3.83 and a 52 week high of $7.77. The company’s market cap is $238 million.
vTv Therapeutics Inc. (VTVT) last announced its earnings results on Aug 2, 2017. The company reported -0.41 earnings per share (EPS) for the quarter, higher than the consensus estimate of -0.43 by $0.02. The company had revenue of $0 million for the quarter, compared to the consensus estimate of $0 million. During the same quarter in the previous year, the company posted -0.47 earnings per share. The company’s revenue for the quarter was down 93% on a year-over-year basis.
|earnings per share||-0.41||-0.35||-0.49|
Latest posts by William White (see all)
- Insider Trading Review: FS Investment Corporation $FSIC - January 13, 2018
- Insider Trader Watch: ENERTOPIA CORP $ENRT - January 13, 2018
- Insider Trading in Focus: Swiss Helvetia Fund, Inc. (The) $SWZ - January 13, 2018